TVGN — Tevogen Bio Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapValue Trap

Annual balance sheet for Tevogen Bio Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash
Cash and Short Term Investments	7.12	5.48	0.009
Net Total Accounts Receivable
Net Total Receivables	—	—	0.344
Prepaid Expenses
Total Current Assets	7.17	5.84	0.356
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.143	1.31	—
Long Term Investments
Other Long Term Assets
Total Assets	7.66	7.74	17
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.668	1.96	3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	24.1	41.7	17.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-16.5	-34	-0.696
Total Liabilities & Shareholders' Equity	7.66	7.74	17
Total Common Shares Outstanding